Proposed breakpoints for infective endocarditis (14 Sept - 25Oct, 2024). Use the EUCAST form for comments to consultations .
Get to know moreComments and EUCAST responses to the open consultations on Brucella melitensis and Bacillus anthracis proposed breakpoints and methods are now published.
Get to know moreDocuments (breakpoint tables, methods and FAQs) related to Rapid Antimicrobial Susceptibility Testing directly from positive blood culture bottles have been revised.
Get to know moreThe guidance document on " What to do when there are no breakpoints " has been updated with recommendations for cefiderocol.
Get to know moreAminoglycoside breakpoints – the EUCAST approach and what this means for the clinician. C. Giske et al, 2025. Abstract in CMI.
Get to know moreOptimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring; Boston, United States, 9 – 10 October 2023.
Get to know moreWarning issued concerning cefiderocol susceptibility testing : there is currently no commercially available functioning test for cefiderocol MIC determination. EUCAST has investigated those available and all have problems with accuracy, reproducibility, bias and/or for some, with skipped wells. For…
Get to know moreThree months ahead of releasing breakpoints and disk diffusion correlates EUCAST publishes the methodology, the QC criteria and a disk diffusion reading guide .
Get to know moreEUCAST has releaed a general consultation and invites comments on proposed changes to aminopenicillin breakpoints for Enterobacterales (30 Nov, 2021 - 14 Jan, 2022).
Get to know moreEUCAST updates the FAQ at regular intervals. Mostly questions are added and in some cases replies are modified because of changes in breakpoints or recommendations.
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.